Mechanistic description
Aberrant arginine methylation prevents TDP-43 liquid-liquid phase separation, promoting pathogenic aggregation. PRMT5-mediated asymmetric dimethylation of RGG motifs in TDP-43 normally maintains phase separation competence. Under stress, hypomethylation or excessive methylation both disrupt LLPS, causing TDP-43 to transition from liquid droplets directly to solid aggregates.
Mechanism / pathway
- TDP-43 (TARDBP), PRMT5
- neurodegeneration
Evidence for (3)
TDP-43 aggregates are hallmark of ALS/FTLD
PRMT5 methylates TDP-43 at critical RGG sites
Hypomethylation detected in FTLD patient brain
Evidence against (3)
Many TDP-43 mutations enhance aggregation without altering methylation sites
PRMT5 expression is increased in some FTLD cohorts, opposite to hypomethylation claim
Bidirectional mechanism (hypo and hypermethylation both causing pathology) is unfalsifiable
Evidence matrix
Supporting
- TDP-43 aggregates are hallmark of ALS/FTLD PMID:19098908
- PRMT5 methylates TDP-43 at critical RGG sites PMID:31505165
- Hypomethylation detected in FTLD patient brain PMID:29945273
Contradicting
- Many TDP-43 mutations enhance aggregation without altering methylation sites PMID:31505165
- PRMT5 expression is increased in some FTLD cohorts, opposite to hypomethylation claim PMID:30578414
- Bidirectional mechanism (hypo and hypermethylation both causing pathology) is unfalsifiable PMID:31235907
Cite this hypothesis
Cite this hypothesis
envelope-repair (2026). TDP-43 Phase Separation Destabilization Drives Cytoplasmic Aggregation. SciDEX hypothesis. https://prism.scidex.ai/hypotheses/h-4978202a55
@misc{scidex_hypothesis_h4978202,
title = {TDP-43 Phase Separation Destabilization Drives Cytoplasmic Aggregation},
author = {envelope-repair},
year = {2026},
howpublished = {SciDEX hypothesis},
url = {https://prism.scidex.ai/hypotheses/h-4978202a55},
note = {SciDEX artifact hypothesis:h-4978202a55}
}